Sign in
4

Changes in Ownership

NEUROCRINE BIOSCIENCES INC Filed Acc 0001209191-19-045763

Chief Executive Officer acquired 3,031 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

GORMAN KEVIN CHARLES · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2019-08-09 Exercise or conversion : show line 1 in the form +3,031 $32.99 $99,993 420,628 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
2019-08-09 Exercise or conversion : show line 2 in the form Incentive Stock Option −3,031 $32.99 $99,993 $32.99 2025-02-03 3,031 0 D
Loading xslF345X03/doc4.xml…